ERBB2 and breast cancer: Figure 2 shows the distribution of BC subtypes (HER2−/HR+, HER2+/HR+, HER2+/HR−, HER2-low/HR+, HER2-low/HR−, HER2−/HR−) according to the PAM50 intrinsic subtypes.